Copiktra Capsule
Product Images NDC 73116-225

8 FDA label images from Secura Bio, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Copiktra (NDC 73116-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Secura Bio, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (30ff13f0 1e77 43de 99c9 C309834f1e63 01)

Image (30ff13f0 1e77 43de 99c9 C309834f1e63 01)
Chemical structure of duvelisib, showing the molecular arrangement including chlorine, oxygen, nitrogen atoms, and a water molecule (H2O). The structure depicts the key functional groups present in this oral prescription drug capsule ingredient.*
FDA Label Image

Image (30ff13f0 1e77 43de 99c9 C309834f1e63 02)

Image (30ff13f0 1e77 43de 99c9 C309834f1e63 02)
A Kaplan-Meier curve chart depicting the probability of progression-free survival over time in months for two treatments: COPIKTRA 25 mg BID (95 patients) and Ofatumumab (101 patients). The blue line represents COPIKTRA, and the red line represents Ofatumumab, with censored data points marked. The chart includes a table showing the number of patients at risk at various time points for both treatments.*
FDA Label Image

25 mg (30ff13f0 1e77 43de 99c9 C309834f1e63 03)

25 mg (30ff13f0 1e77 43de 99c9 C309834f1e63 03)
Copiktra (duvelisib) 25 mg capsules packaging label from Secura Bio, Inc. The label indicates the oral capsule form with 25 mg strength, containing 56 capsules per container. The design features the brand and generic name prominently, with dosage instructions, storage conditions, NDC 73116-225-56, and manufacturer details from Secura Bio, Inc., Berkeley Heights, NJ.*
FDA Label Image

25 mg (30ff13f0 1e77 43de 99c9 C309834f1e63 04)

25 mg (30ff13f0 1e77 43de 99c9 C309834f1e63 04)
Packaging label for COPIKTRA (duvelisib) Capsules, 25 mg strength. The label shows a two-week blister pack design with separate sections for AM (orange) and PM (blue) doses. Each section contains 14 days of individual capsule compartments. The label includes the proprietary name COPIKTRA, the generic name duvelisib, and the dosage strength of 25 mg per capsule.*
FDA Label Image

25 mg (30ff13f0 1e77 43de 99c9 C309834f1e63 05)

25 mg (30ff13f0 1e77 43de 99c9 C309834f1e63 05)
Packaging label for COPIKTRA (duvelisib) capsules, 25 mg per capsule, manufactured by Secura Bio, Inc. The label features the brand and generic name prominently, a depiction of a capsule, dosage strength, and instructions to administer one capsule twice daily. The container holds 28 capsules, with handling instructions and storage information included.*
FDA Label Image

15 mg (30ff13f0 1e77 43de 99c9 C309834f1e63 06)

15 mg (30ff13f0 1e77 43de 99c9 C309834f1e63 06)
Packaging label for Copiktra (duvelisib) capsules 15 mg per capsule, manufactured by Secura Bio, Inc. The label shows a carton that contains 56 capsules in 2 blister packs of 28 each, with clear dosage and storage instructions. The label includes the NDC 73116-215-56 and emphasizes the oral capsule dosage form.*
FDA Label Image

Desc (30ff13f0 1e77 43de 99c9 C309834f1e63 07)

Desc (30ff13f0 1e77 43de 99c9 C309834f1e63 07)
A 14-day blister card packaging for COPIKTRA (duvelisib) oral capsules, 15 mg per capsule. The card is divided into two rows labeled AM (orange) and PM (blue) for morning and evening doses, with each day numbered from 1 to 14. The label includes the product name, strength, and dosage form. Secura Bio, Inc is the labeler.*
FDA Label Image

15 mg (30ff13f0 1e77 43de 99c9 C309834f1e63 08)

15 mg (30ff13f0 1e77 43de 99c9 C309834f1e63 08)
COPIKTRA (duvelisib) Capsules 15 mg per capsule packaging label by Secura Bio, Inc. The label indicates each bottle contains 28 capsules with oral administration instructions, and includes the manufacturer's location, storage directions, and tamper-evident packaging details. The design uses blue, orange, black, and white colors with dosage strength clearly marked.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.